Our 4,000 sq.m. processing, manufacturing and R&D facility, is designed to comply with E.U. GMP requirements with the aim to become a center of excellence for researching and manufacturing medical cannabis products. Our processing facility will make use of the latest technology in oil extraction as well as encapsulation to deliver a consistent product to our patients. During phase 2, the processing area will increase by 2,500 sq.m.